|
Melissa Zipin joined LP&P in 1998 and has more than 14 years of experience in medical device, health technology and consumer tech public relations and advertising. Melissa currently serves as the lead of the agency’s Life Sciences Practice. Melissa has extensive experience launching medical device and health technology companies and products. She spearheaded Restore Medical’s national and regional launch of the first implantable device for treating sleep apnea, which resulted in more than 500 million impressions with coverage in The Wall Street Journal, News Day, Reader’s Digest and Woman’s Day and on The Tonight Show, Good Morning America, CNNand more than 1,200 regional broadcast outlets in all 50 states. Melissa has relationships with medical producers and editors at key media outlets including The TodayShow, Good Morning America, New York Times, CNN, NBC Nightly News, Discovery Health Channel, Reader’s Digest and Reuters Health, among others. In addition, Melissa’s experience includes working with both private and public companies, leading programs specifically designed for patient recruitment, physician and consumer awareness, issues-driven campaigns, as well as company repositioning. Her Life Sciences clients have included: Restore Medical (medical devices for treating sleep-disordered breathing), EnteroMedics (obesity management system), MedicalCV (minimally-invasive atrial fibrillation treatment), Hurricane Voices (breast cancer foundation), Gynecare (women’s health therapies, now part of Ethicon), InControl (implantable atrial defibrillator, acquired by Guidant), Vital-Link (emergency response systems), TargetRx (pharmaceutical marketing information), Medidata (electronic clinical data management), Clinsoft (clinical data management), Galt Associates (pharmacovigilance), Xpogen (bioinformatics), and HealthGate (health content management).Melissa received the Silver Anvil Award from the Public Relations Society of America and Bell Ringer Awards from the Publicity Club of New England for her work launching the first outpatient, non-invasive alternative to hysterectomy for the treatment of menorhaggia for Gynecare, Inc., and for Restore Medical. In addition, she led programs for the repositioning, name-change and launch of Clinsoft, which positioned the company as an attractive acquisition for its nearest competitor. Melissa holds a B.A. in Fashion Marketing from Simmons College in Boston. | 